Steer clear of any provider brazenly selling ITC-banned GLP-1 compounds like a exploration chemical — That could be a compliance pink flag for the entire operation.The fiscal implications are obvious: every dollar that was flowing to grey market peptide sellers is currently possibly likely to respectable pharmaceutical channels or evaporati… Read More